@@ΰ
««ΉηξΜaff
ηξΦAβ`qΟΩΜffp
νξν@@T1@@@η@κχ1,2
i1ͺεwa@aEaffΘC2ͺεwγwawuΐj
v|: ««ΉηξΜgDEΧEfΙζιffmθΝdvΕ ιͺCηξΖ½«ηBΜΣΚΝCΙ’οΘκΰ ιBΕίΕΝCξαΜβ`qΩνΙ Ϊ΅½V΅’ff@iancillary assayjΜJEpͺffΈxΜόγΙε«v£΅Δ’ιBΖugD»wiimmunohistochemistry, IHCjβfluorescence in situ hybridizationiFISHjΙζιβIAbZCΝCgDΜβΧEfΜΙ¨’ΔCηNΉΜΧEΜΗ««π100%ΜΑΩxΕΣΚΒ\Ε ιͺCηξΜ‘ΓϋjβϊaΟΜ―θΙ¨’Δε«ΘeΏπ^¦ι½ίCΚπ]Ώ·ιΫΙN±θ€ιpitfallπF―΅CTdΙp’ιKvͺ ιB
L[[h:Mesothelioma, FISH, Immunohistochemistry, Diagnostic application, Ancillary assay
Pathological diagnosis of malignant pleural mesothelioma:diagnostic application of genomic-based ancillary assay
Makoto Hamasaki1 and Kazuki Nabeshima1,2
1Department of Pathology, Fukuoka University Hospital
2Department of Pathology, Fukuoka University School of Medicine
i_Άσt:2020N1224ϊj
iΜpθ:2021N129ϊj